GeoVax CEO David Dodd Responds to President Trump’s State

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
20
GeoVax CEO David Dodd Responds to President Trump’s State of the Union Message

Applauding HIV Elimination Goals and Encouraging More Resources Toward Vaccine Development

ATLANTA, GA, Feb. 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- GeoVax Labs, Inc. (OTCQB: GOVX). During Tuesday night’s State of the Union address, President Donald Trump asked Congress to support his goal of eliminating the HIV epidemic in America within 10 years. GeoVax’s President and CEO, David Dodd, responded today.

“We applaud President Trump for using such a high-profile setting to bring attention to the continued HIV epidemic in the United States,” Mr. Dodd commented. “Tremendous strides have been made in HIV awareness and treatment over the past three decades. However, despite the availability of effective HIV medications and the best efforts of community education and prevention programs, the tide of new HIV infections has not been reversed.

“Under current plans championed by top health officials, the spread of HIV might be slowed down through expansion and re-focusing of current prevention and treatment efforts, but the strategy will be doomed to failure without an effective vaccination program as a central focus. It is disheartening to recognize that many public policy leaders appear to be satisfied that HIV in the United States is now a chronic, treatable condition… our society deserves and ought to demand more. Much like the polio and smallpox eradication efforts, it will take a vaccine to eliminate HIV.”

Burden on the U.S. Taxpayer

Mr. Dodd stated, “More than 1.1 million people in the United States are infected with HIV, with nearly 40,000 new infections each year. Based on President Trump’s FY2018 budget request, the U.S. government is spending a staggering  $26.6 billion each year  for domestic HIV/AIDS programs, less than 10% of which goes toward medical research (even less for vaccines). Without a vaccine or immunotherapy cure for HIV, the financial burden to U.S. taxpayers will continue to increase each year with no end in sight.”

Call for a New Mindset for HIV Vaccine Development

“GeoVax has the leading preventative HIV vaccine candidate designed to fight against the subtype of HIV prevalent in the United States,” Mr. Dodd continued. “We have benefited from U.S. government support for our human clinical trials, and we have the greatest respect for the many individuals at the National Institutes of Health (NIH) and the HIV Vaccine Trials Network (HVTN) who have worked on our vaccine program.

“However, the progress of our HIV vaccine development has been hampered by governmental financial constraints, contributing to a risk-averse attitude held by many public policy officials… a resistance to commit financial and other resources toward rapidly advancing experimental programs such as ours. Our program is moving forward with NIH support, and for that we are thankful; but the pace could be much quicker.

“In his budget proposal to Congress, I encourage President Trump to make vaccine development a central pillar of his HIV elimination strategy, and to take lessons from the private sector by encouraging calculated risks by public health policy decision-makers. Our country should set higher goals for addressing the U.S. HIV epidemic, ones that seek a cost-effective eradication approach and not just expensive and never-ending chronic disease management.”

About GeoVax

GeoVax Labs, Inc., is a clinical-stage biotechnology company developing human vaccines against infectious diseases using its patented MVA-VLP vaccine platform. GeoVax was the winner of the 2018 “Best Biotech” Vaccine Industry Excellence Awards, a finalist for the 2018 “Best Prophylactic Vaccine” Award for its Zika vaccine at the World Vaccine Congress, as well as a finalist for Pipelines of Promise at Buzz of Bio 2018. The Company’s development programs are focused on vaccines against HIV, Zika, hemorrhagic fever viruses (Ebola, Sudan, Marburg and Lassa) and malaria. GeoVax also is evaluating the use of its MVA-VLP platform in cancer immunotherapy, and for therapeutic use in chronic Hepatitis B infections and in treating Human Papillomavirus (HPV) infections. GeoVax’s vaccine platform supports  in vivo production of non-infectious VLPs from the cells of the very person receiving the vaccine. The production of VLPs in the person being vaccinated mimics virus production in a natural infection, stimulating both the humoral and cellular arms of the immune system to recognize, prevent, and control the target infection. For more information, visit  https://www.geovax.com .

Forward-Looking Statements

Certain statements in this document are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act. These statements are based on management's current expectations and are subject to uncertainty and changes in circumstances. Actual results may differ materially from those included in these statements due to a variety of factors, including whether:  GeoVax can develop and manufacture its vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent HIV or Ebola infection in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements and does not intend to do so. More information about these factors is contained in GeoVax's filings with the Securities and Exchange Commission including those set forth at "Risk Factors" in GeoVax's Form 10-K.

GeoVax Labs, Inc. 678-384-7220 investor@geovax.com 

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Endava's Audit Scandal: Investors Face Crucial Decision

Updated Category News Views 14

Endava's Unexpected Crisis: What's Happening? It's the kind of mess no investor wants to wake up to: on October 28, 2026, Endava plc (NYSE: DAVA) laid out a smorgasbord of screw-ups that have left the market reeling. The company's last few days were a whirlwind, featuring the CFO's abrupt exit and the CEO swap. This shake-up didn't happen in isolation—the announcement...

Continue Reading
Fluence Energy Faces Heat: Class Action Lawsuit Unfolds

Updated Category News Views 25

Fluence Energy's Difficult Waters Investors in Fluence Energy (NASDAQ: FLNC) are having a moment of reckoning, no doubt. November 2nd saw a nearly 9% drop in FLNC stock, further fueled by the sudden departures of the CEO and CFO just days earlier. This marks a bitter chapter for Fluence as its stock continues to bleed, leaving many wondering what seismic shifts are yet to...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 193

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Salvation Army’s Angel Tree: 2026 Holiday Cheer Drive

Updated Category News Views 9

Kickstarting Holiday Generosity: The Angel Tree Program Man, there's something heartwarming about a Christmas that shines bright for everyone. The Salvation Army's Angel Tree program is back for another season, rolling up with a mission to spark joy across the country. For over 45 years now, this initiative's been the answer to many Christmas wish lists, especially for...

Continue Reading
Veritran's Bold Move: Acquiring PrismaCampaigns Inc.

Updated Category News Views 58

Veritran's Strategic Leap Forward They're not messing around, folks. Veritran just made a power move by acquiring 100% of PrismaCampaigns Inc., and it’s more than just another day in the office. This marks a pivotal expansion of their American footprint, and they're zeroing in on our banks and credit unions with laser precision. Why This Matters for Financial...

Continue Reading
Scientific Games Joins NCPG’s 2026 Campaign Again

Updated Category News Views 74

Scientific Games Backs Responsible Gaming Again It's another year, and here's Scientific Games once more, guns blazing for a cause that's needed more than a few times over—responsible gambling. Those folks got their hearts in the right place, joining the National Council on Problem Gambling's 2026 Gift Responsibly campaign. Ninth time running, no less! It's like...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 117

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Cinmoore's Smart Camera: A Game Changer for Car Security

Updated Category News Views 32

Pioneering Car Security with Cinmoore's Smart Camera Ever left your car in the parking lot, heart pounding, wondering if it's safe while you run errands? Well, Cinmoore might just quell that parking paranoia with their new gizmo, the Smart Parking Camera DC1U. This device isn't just some fancily-packaged disappointment—it promises some serious peace of mind for those...

Continue Reading
Ballard's Q3 2026: Navigating Losses and Bold Moves

Updated Category News Views 80

Ballard’s Financial Puzzles in Q3 2026 Riding the rough waters of the third quarter in 2026, Ballard Power Systems set out its stall with some eyebrow-raising numbers. This ain't the bustling diner vibe we normally see for a thriving business. The results paint a cautious picture sprinkled with strategic shifts that demand a keen eye. GeoPura Acquisition: A Strategic...

Continue Reading
Baidu's Q3 2026: AI Explodes Amid Marketing Slump

Updated Category News Views 35

Baidu Looks to AI as Revenue Driver in Q3 2026 You know, Baidu's got one heck of a story this quarter. Despite some clouds hanging over them, they’ve managed to find a silver lining in their AI ventures. It’s like they’ve got this magic bullet with AI Cloud growth skyrocketing 94% year over year. That’s not just a rabbit outta the hat; it’s more like pulling a...

Continue Reading

Top 5 Most Recently Viewed Articles

AEX Index Climbs as Technology Sector Shines Bright

Updated Category News Views 246

AEX Index Climbs as Technology Sector Shines Bright The AEX index in the Netherlands showcased a remarkable performance following gains across multiple sectors during a recent trading session. The technology, consumer goods, and consumer services sectors were significant contributors to this upward trend, reflecting the overall market optimism. Market Performance Overview...

Continue Reading
Comoto Partners with Motorcycle Industry Council to Boost Riding

Updated Category News Views 337

Comoto and the MIC Collaborate for Motorcycling Growth The Comoto Family of Brands, which includes names like Cycle Gear, RevZilla, and J&P Cycles, has recently announced an exciting partnership with the Motorcycle Industry Council (MIC). This collaboration aims to ignite the passion for motorcycle riding among new and potential riders through innovative educational...

Continue Reading
Oxford Treatment Center Launches Evening Addiction Services

Updated Category News Views 288

Oxford Treatment Center Enhances Addiction Care Availability Oxford Treatment Center is excited to announce the launch of its new evening intensive outpatient program (IOP), designed specifically for those in Southaven seeking flexible addiction care. This initiative addresses a crucial gap in services for individuals juggling daytime obligations, such as work or school,...

Continue Reading
Anticipating Earnings: Insights for MeridianLink (MLNK)

Updated Category News Views 146

MeridianLink's Earnings Outlook MeridianLink (NYSE: MLNK) is gearing up to announce its quarterly earnings soon, which has investors excited about what lies ahead. As the moment approaches, there are critical factors that stakeholders should consider to navigate the upcoming report effectively. Anticipated Earnings Analysis Expectations are set for MeridianLink to unveil...

Continue Reading
BCT - The Community's Bank Celebrates Loudoun's Favorite Honors

Updated Category News Views 145

BCT - The Community's Bank Wins Loudoun's Favorite Awards BCT - The Community's Bank has been recognized by residents as one of Loudoun's Favorite banks, having won multiple awards in the recent annual reader's poll. This recognition reflects the bank's unwavering dedication to providing top-notch financial services to its local community. For the second consecutive year,...

Continue Reading